Lyon Street Capital, LLC - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$545,000
-92.5%
42,396
-94.4%
1.68%
-77.0%
Q4 2018$7,248,000
-69.9%
762,941
-47.4%
7.29%
-51.4%
Q3 2018$24,098,000
+2.0%
1,451,700
-1.3%
15.01%
+78.7%
Q2 2018$23,618,000
+24.4%
1,471,518
+18.5%
8.40%
+37.3%
Q1 2018$18,992,000
+46.8%
1,241,293
+49.7%
6.12%
+41.8%
Q4 2017$12,934,000
+115.2%
829,090
+53.1%
4.31%
+86.1%
Q3 2017$6,010,000
+420.3%
541,462
+331.1%
2.32%
+398.3%
Q2 2017$1,155,000125,5950.46%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders